World · Singapore Bureau
Singapore launches subsidised genetic screening for hereditary cancer risk
A new scheme beginning December 1 will offer affordable testing to identify carriers of genes linked to hereditary breast and ovarian cancer. The Ministry of Health expects the programme to benefit approximately 2,000 individuals annually.
LSN Singapore ·
Singapore is rolling out a subsidised genetic testing initiative aimed at identifying individuals carrying hereditary mutations associated with breast and ovarian cancer. The scheme commences on December 1 and represents an expanded effort to detect gene carriers at an early stage, potentially enabling preventive health measures.
The Ministry of Health projects the programme will reach around 2,000 people each year, helping to identify those at heightened risk due to genetic predisposition. Early identification of such carriers is considered crucial for personalised clinical management and family counselling.
Genetic testing for hereditary cancer syndromes has traditionally required significant out-of-pocket expenditure for residents. By subsidising these tests, the healthcare system aims to improve accessibility and encourage uptake among at-risk populations.
The initiative aligns with Singapore's broader preventive healthcare strategy, emphasising early detection and intervention in cancer risk management. Healthcare providers are expected to guide eligible individuals through the testing process and genetic counselling services.